Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
Stopped Lack of funding
Conditions
- Brain and Central Nervous System Tumors
- Lymphoma
- Neurotoxicity
Interventions
- BIOLOGICAL: Rituximab
- DRUG: Cytarabine
- DRUG: Methotrexate
- DRUG: Motexafin gadolinium
- DRUG: Procarbazine hydrochloride
- DRUG: Vincristine sulfate
- RADIATION: Radiation therapy
Sponsor
Northwestern University
Collaborators